Johnson & Johnson Reserve $600 Million of Second Quarter Earnings for Settlement

The pharmaceutical giant Johnson & Johnson has set aside $600 million in anticipation of a possible settlement. The plaintiffs have alleged that Johnson & Johnson gave kickbacks to nursing homes that would purchase the Johnson & Johnson anti-psychotic medications, Risperdal and Invega as well as the respiratory drug Natrector. It is speculated that the $600 million is being used to finance a $2.2 billion dollar settlement.

This set aside of $600 million comes on the heels of various 2011 recalls. Johnson & Johnson has recently has recalled products ranging from contact lenses to hip replacements to even Tylenol.

http://kansascity.injuryboard.com/fda-and-prescription-drugs/johnson-johnson-reserves-additional-600-million-for-settlement.aspx?googleid=301846

No Comments

Leave a comment
Comment Information
Email Us For A Response

Tell Us About Your Serious Injuries

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

San Jose Office
2007 West Hedding Street
Suite 100
San Jose, CA 95128

Phone: 408-292-2434
Fax: 408-292-1264
San Jose Law Office Map

Montery Office
2600 Garden Road
Montery, CA 93940

Phone: 831-620-1212
Montery Law Office Map